UBS Group
FHLTW

UBS Group’s Future Health ESG Corp. Warrant FHLTW Stock Holding History

UBS Group’s Portfolio FHLTW Stock Details FHLTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,500
Closed -$315 – 10795
2022
Q4 		$315 Buy
+4,500
New +$306 ﹤0.01% 10252

Other funds holding FHLTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

UBS Group's FHLTW Position: Q1 2023 in Review

UBS Group sold out of Future Health ESG Corp. Warrant (FHLTW) in Q1 2023, closing a stake of 4,500 shares — an estimated $315 sold.

UBS Group first reported a position in FHLTW in Q4 2022 and held it in 1 quarter. The position peaked at $315 in Q4 2022. 29 funds tracked by Wall St. Rank hold FHLTW as of Q1 2023.

  • UBS Group reported no remaining Future Health ESG Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 4,500 Future Health ESG Corp. Warrant shares in Q1 2023, an estimated $315.
  • UBS Group first reported a position in Future Health ESG Corp. Warrant in Q4 2022 and held it in 1 quarter.
  • UBS Group's Future Health ESG Corp. Warrant position peaked at $315 in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Future Health ESG Corp. Warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.